Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with pancreatic cancer (a specific type called adenocarcinoma) that is either borderline removable by surgery, too advanced for surgery, or where surgery is not safe for medical reasons, confirmed by a tissue or cell sample.
- People who are generally well enough to carry out light activity and care for themselves, but may not be able to do heavy physical work (this is measured on a standard scale called ECOG, scores 0–1).
- People who have already received at least two months of chemotherapy before starting this trial's treatment.
- People whose cancer has spread to no more than 3 nearby lymph nodes (the nodes must be close to the main tumour and show signs of involvement on scans or confirmed by testing).
- People who are at least 18 years old.
- People who are able to pause their regular cancer medication for at least one week before and at least one week after the trial treatment (two weeks on each side is preferred).
- People who are able to hold their breath at the end of a breath out for at least 20 seconds, and able to do repeated breath-holds of at least 10 seconds when instructed.
- People whose tumour and surrounding areas can be clearly seen on the planning scan used for this trial's radiation treatment, as confirmed by the treating doctors.
- People who are able to understand and willing to sign an informed consent form (or have a legal representative do so on their behalf).
Who may not be able to join:
- People who have previously had radiation therapy in the same area of the body where this trial's treatment would be delivered.
- People who have received, are currently receiving, or are planning to receive any experimental (investigational) treatments for pancreatic cancer within 90 days before or after the trial's radiation treatment.
- People who have been diagnosed with another active cancer within the past year.
- People who have serious uncontrolled health conditions, such as an active infection, uncontrolled heart failure, unstable chest pain, irregular heart rhythms, or mental health or personal circumstances that would make it difficult to follow the trial requirements.
- People whose tumour has grown directly into the stomach or the first part of the small intestine (duodenum), as seen on scans or a camera examination.
- People who are pregnant or breastfeeding. People who could become pregnant must have a negative pregnancy test within 14 days of entering the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lauren Henke, MD, Case Western Reserve University
Phone: 206-218-8173
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Acute Grade 3+ treatment related GI toxicities
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.